MARS®: The new frontier in treating acute liver failure
A type of dialysis, MARS removes toxins and replaces lost liver functions.
Endocrinology
FDA approves new stent for treatment of pseudocysts of the pancreas
On Dec. 18, the U.S. Food and Drug Administration (FDA) allowed marketing of the AXIOS Stent and Delivery System for treating pseudocysts that form…
Study: Antihypertensives decrease risk of Alzheimer disease
Diuretics, angiotensin-1 receptor blockers, and angiotensin-converting enzyme inhibitors seemed to reduce the risk of Alzheimer disease (AD), according to a study, published in Neurology,…
Study: Lower blood glucose may be good for brain function
Even for people who don’t have diabetes, those who have higher glucose levels are more likely to have memory problems, according to a study…
Study: Antidepressants may pose risk for type 2 diabetes
A systematic review published in Diabetes Care reports that that people taking antidepressants are at a higher risk of type 2 diabetes, although it’s…
Study: High glucose in patients with diabetes increases risk of dehiscence after surgery for chronic wounds
A study published in Plastic and Reconstructive Surgery reports that preoperative and postoperative hyperglycemia and elevated A1c in patients with diabetes increases the risk…
Improving depression screening in patients with chronic illness
Don’t miss an opportunity for health promotion and improvement in disease management by failing to assess patients with chronic illness for depression.
Improving insulin adherence in diabetes care
By addressing patients’ concerns, you can help them adhere to insulin therapy with less pain and anxiety.
FDA tells companies to stop illegal sale of treatments for diabetes
The U.S. Food and Drug Administration (FDA) recently issued warning letters to 15 companies, notifying them the sale of their illegally marketed diabetes products…
FDA approves new diabetes drug
On March 29, the U.S. Food and Drug Administration (FDA) approved Invokana (canagliflozin) tablets to treat adults with type 2 diabetes. Invokana has been…
FDA approves new drug treatments for type 2 diabetes
On Jan. 25, 2013, the U.S. Food and Drug Administration (FDA) approved three new related products for the treatment of type 2 diabetes: Nesina…
MARS®: The new frontier in treating acute liver failure
A type of dialysis, MARS removes toxins and replaces lost liver functions.
FDA approves new stent for treatment of pseudocysts of the pancreas
On Dec. 18, the U.S. Food and Drug Administration (FDA) allowed marketing of the AXIOS Stent and Delivery System for treating pseudocysts…
Study: Antihypertensives decrease risk of Alzheimer disease
Diuretics, angiotensin-1 receptor blockers, and angiotensin-converting enzyme inhibitors seemed to reduce the risk of Alzheimer disease (AD), according to a study, published…
Study: Lower blood glucose may be good for brain function
Even for people who don’t have diabetes, those who have higher glucose levels are more likely to have memory problems, according to…
Study: Antidepressants may pose risk for type 2 diabetes
A systematic review published in Diabetes Care reports that that people taking antidepressants are at a higher risk of type 2 diabetes,…
Study: High glucose in patients with diabetes increases risk of dehiscence after surgery for chronic wounds
A study published in Plastic and Reconstructive Surgery reports that preoperative and postoperative hyperglycemia and elevated A1c in patients with diabetes increases…
Improving depression screening in patients with chronic illness
Don’t miss an opportunity for health promotion and improvement in disease management by failing to assess patients with chronic illness for depression.
Improving insulin adherence in diabetes care
By addressing patients’ concerns, you can help them adhere to insulin therapy with less pain and anxiety.
FDA tells companies to stop illegal sale of treatments for diabetes
The U.S. Food and Drug Administration (FDA) recently issued warning letters to 15 companies, notifying them the sale of their illegally marketed…
FDA approves new diabetes drug
On March 29, the U.S. Food and Drug Administration (FDA) approved Invokana (canagliflozin) tablets to treat adults with type 2 diabetes. Invokana…
FDA approves new drug treatments for type 2 diabetes
On Jan. 25, 2013, the U.S. Food and Drug Administration (FDA) approved three new related products for the treatment of type 2…
Poll
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.